<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">AJPS</journal-id><journal-title-group><journal-title>American Journal of Plant Sciences</journal-title></journal-title-group><issn pub-type="epub">2158-2742</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ajps.2016.73038</article-id><article-id pub-id-type="publisher-id">AJPS-64403</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biomedical&amp;Life Sciences</subject></subj-group></article-categories><title-group><article-title>
 
 
  Chemical Composition of the Fatty Oil from Fructus Broussonetiae and Its Effects on Rat Plasma Lipids and Adipose Tissue
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>u-Qiu</surname><given-names>Pang</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Guo-Quan</surname><given-names>Wang</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Xiao-Qin</surname><given-names>Jin</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ai-Jing</surname><given-names>Sun</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Jun-Sheng</surname><given-names>Lin</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Yong</surname><given-names>Diao</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff2"><addr-line>Department of Pharmacy, Haixia Hospital, Quanzhou, China</addr-line></aff><aff id="aff1"><addr-line>School of Biomedical Sciences, Huaqiao University, Quanzhou, China</addr-line></aff><author-notes><corresp id="cor1">* E-mail:<email>1074730795@qq.com(UP)</email>;</corresp></author-notes><pub-date pub-type="epub"><day>10</day><month>03</month><year>2016</year></pub-date><volume>07</volume><issue>03</issue><fpage>446</fpage><lpage>452</lpage><history><date date-type="received"><day>30</day>	<month>January</month>	<year>2016</year></date><date date-type="rev-recd"><day>accepted</day>	<month>6</month>	<year>March</year>	</date><date date-type="accepted"><day>10</day>	<month>March</month>	<year>2016</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Context: Broussonetia papyrifera (L.) Vent. (Moraceae), a traditional Chinese medicinal herb, has been extensively applied for many years to treat various diseases. Its fruits (Fructus Broussonetiae) have been commonly used as an important tonic for the treatment of age-related disorders with long history; recent research has proved that it contains 32% to 35% fixed oils. The fixed oil is composed mainly of unsaturated fatty acids, including linoleic acid, methyl palmitate, oleic acid and linoleic acid ester. 
  Objective: To investigate the chemistry of the fatty oil from Fructus Broussonetiae (FOFB) and its effects on plasma lipids. 
  Methods: The chemical composition of FOFB was examined and identified by GC-MS. Thirty male Wistar rats fed diet containing FOFB and cholesterol were studied for 28 days. The effect of dietary FOFB on plasma lipids and adipose tissue was tested. 
  Results: Twelve compounds of FOFB were examined and identified, the major components of fatty oil, 8,11-octadecadienoic acid (83.75%), palmitic acid (10.22%), octadecadienoic acid (2.97%) and 9-octadecenoic acid (1.69%) were found. FOFB significantly exhibited the activities of decreasing the rat adipose tissue weight, triacylglycerol, total cholesterol, and low-density lipoprotein cholesterol (LDL-C) concentrations while the rat body weight remained unchanged. 
  Discussion: FOFB contained a large amount of PUFA which had the effect on reducing plasma lipids and adipose.
 
</p></abstract><kwd-group><kwd>Fructus Broussonetiae</kwd><kwd> Polyunsaturated Fatty Acids</kwd><kwd> Plasma Lipids</kwd><kwd> Adipose Tissue</kwd><kwd> Rat</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Unsaturated fatty acid (USFA) is a kind of body fat acid, and the most essential body fatty acids are USFA. USFA, according to the different numbers of the double bond, is divided into monounsaturated fatty acid (MUFA) and polyunsaturated fatty acids (PUFA). In the dietary fats, MUFA includes oleic acid, and PUFA includes linoleic acid, linolenic acid, arachidonic acid, etc. Linoleic acid and linolenic acid cannot be synthesized by human body; they must be supplied by the diet. If the dietary unsaturated fatty acid is insufficient, it is easy to cause the blood low-density lipoprotein and LDL-cholesterol increasing, which can cause atherosclerosis and cardiovascular diseases.</p><p>Broussonetia papyrifera (L.) Vent. (Moraceae) is a deciduous plant widely distributed all over China. Fruits of the plant are commonly named Fructus Broussonetiae (FB). In traditional Chinese medicine, FB is used to nourish yin and tonify the blood, replenish liver and kidney, improve eyesight and promote urination, and can be used for treating soreness and weakness of waist and knees, fatigue, severe fever and dizziness [<xref ref-type="bibr" rid="scirp.64403-ref1">1</xref>] . And it has been used for impotency and to treat ophthalmic disorders [<xref ref-type="bibr" rid="scirp.64403-ref2">2</xref>] for more than one thousand years. Different extracts of B. papyrifera from a number of laboratories have been shown antifungal [<xref ref-type="bibr" rid="scirp.64403-ref3">3</xref>] , antithepatotoxic [<xref ref-type="bibr" rid="scirp.64403-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.64403-ref5">5</xref>] , antioxidant [<xref ref-type="bibr" rid="scirp.64403-ref6">6</xref>] , lens aldose reductase inhibitory activities [<xref ref-type="bibr" rid="scirp.64403-ref7">7</xref>] , and its extract improves cognitive function and endoplasmic reticulum stress in Alzheimer’s disease models [<xref ref-type="bibr" rid="scirp.64403-ref8">8</xref>] . Fatty oil of FB (FOFB) is rich in polyunsaturated fatty acids (PUFA) [<xref ref-type="bibr" rid="scirp.64403-ref9">9</xref>] , which plays an important role in reducing long-chain saturated fatty acids level by suppression of fatty acid synthase (FAS) [<xref ref-type="bibr" rid="scirp.64403-ref10">10</xref>] . The FOFB has significant antioxidant effect and can scavenge and inhibit oxygen free radical [<xref ref-type="bibr" rid="scirp.64403-ref11">11</xref>] . Furthermore, it is able to suppress LPS induced NO production in RAW264.7 macrophages [<xref ref-type="bibr" rid="scirp.64403-ref12">12</xref>] . In this study, we investigate the chemical components of the FOFB. We also used rats as a model feeding with FOFB diets to investigate the effects of the FOFB on the concentration of plasma lipids, hepatic lipids and the weight of the adipose tissue.</p></sec><sec id="s2"><title>2. Materials and Methods</title><sec id="s2_1"><title>2.1. Raw Materials</title><p>B. papyrifera fruits were collected from Quanzhou, Fujian Province, China in autumn, 2011. The specimens were identified by Prof. HUANG BK (Second Military Medical University). Voucher specimens (voucher No. 20110915) were deposited at School of Biomedical Sciences, Huaqiao University of China. The fresh fruits were washed, dried and the grey white membranous persistent calyx and impurities were removed. FB ( 2.5 kg ) was obtained and stored in a vacuum dryer for further use.</p></sec><sec id="s2_2"><title>2.2. Chemical Analysis of Fatty Oil</title><p>Samples of FOFB were extruded from FB using an extruder (D-1683, Henan, China) at speeds of 70 - 80 rpm. The obtained orange fatty oil samples were analyzed by Gas chromatography-mass spectrometry (GC-MS) (HP 5890/HP 5973 instrument), which was fitted with capillary glass column DB-wax (30 m &#215; 0.25 mm &#215; 0.25 μm). The column was temperature programmed as follow: 50˚C (2 min), 50˚C - 70˚C at 4˚C/min then 70˚C - 300˚C at 10˚C/min with helium as the carrier gas. Injector temperature was 250˚C. Mass spectra were obtained by scanning from m/z 35 to 500 with a 0.7 s scan time.</p><p>The individual oil components were separated and identified by comparison of their retention indices and mass spectra with the NIST 98 and Wiley Mass Spectral Libraries. The relative amounts of individual components were expressed as percentages of the peak area relative to the total peak area.</p></sec><sec id="s2_3"><title>2.3. Animals and Their Treatment</title><p>Experiments in animals were approved by the Laboratory Animal Care Committee of our institution and were conducted in compliance with our institution’s ethical guidelines for animal research.</p><p>Thirty male Wistar rats (5-week-old) were housed individually in metallic cages in an animal room kept at 25˚C &#177; 1˚C and 60% &#177; 5% relative humidity with a 12:12-h light-dark cycle (lighting from 8: 00 a .m. to 8:00 p.m.). The rats were fed with an adaptation diet for 1 week, and then divided randomly into three groups (each group 10 rats) for designed diets: 1) 10% lard (control) group; 2) 5% FOFB group (5% FOFB + 5% lard); 3) 10% FOFB group (10% FOFB). The recipes of the three experimental diets are shown in <xref ref-type="table" rid="table2">Table 2</xref>. Fresh diets and drinking water were available ad libitum for 28 days. Food intake was measured daily, and body weight was measured at every seventh day. Fatty acid compositions of the three experimental diets were determined by Gas chromatography.</p></sec><sec id="s2_4"><title>2.4. Blood and Tissue Sampling</title><p>At the end of the feeding period (4 weeks), the rats were deprived of food for 12 h, and then blood samples (with sodium citrate 0.5 mg/ml as anticoagulant) were collected from fossa orbitalis under chloraldurat anesthesia. After the blood sampling, the animals were killed immediately by dislocating cervical, the heart，liver and adipose tissue were isolated, weighted and immediately frozen and stored at −80˚C until used for analysis. Relative heart (liver, adipose tissue) weight was expressed as heart (liver, adipose tissue) weight (g) &#215;100/final body weight (g).</p></sec><sec id="s2_5"><title>2.5. Measurement of the Plasma Lipids and Lipoproteins</title><p>Plasma samples were obtained by centrifugation (1388 g for 10 min at 10˚C). Plasma total cholesterol (CHO) and triacylglycerol (TG) were determined by CHOD-PAP and GPO-PAP methods using CHO and TG testing kits, respectively. High-density lipoprotein (HDL-C) and Low-density lipoprotein (LDL-C) in plasma were separated by ultracentrifugation (194,000 g for 3 h at 10˚C), and determined by direct method using HDL-C and LDL-C kits. All kits were purchased from Beijing jiuqiang Bio-Tech Com., China. All biochemical indicators were measured using a conventional automated analyzer (Beckman Au680, USA).</p></sec><sec id="s2_6"><title>2.6. Measurement of Liver Cholesterol</title><p>Total cholesterol in the liver was assayed from the total lipids extracted by the Folch method [<xref ref-type="bibr" rid="scirp.64403-ref13">13</xref>] .</p></sec><sec id="s2_7"><title>2.7. Statistical Analysis</title><p>Each result was given as the mean &#177; standard deviations (S.D.). Statistical differences among groups were calculated using one-way ANOVA (SAS Institute, Cary, NC), and group means were considered to be significantly different at p &lt; 0.05 as determined by Duncan’s new multiple-range test.</p></sec></sec><sec id="s3"><title>3. Results and Discussion</title><sec id="s3_1"><title>3.1. Chemical Constituents of Fatty Oil of Fructus Broussonetiae</title><p>GC and MS are powerful tools for chemical analysis, especially when used together. All of the components in a sample can be separated by GC analysis, and at the same time GC analysis provides a representative spectral output. The size of the peak is proportional to the quantity of the corresponding substances in the specimen analyzed. MS identifies substances by electrically charging the specimen molecules, accelerating them through a magnetic field, breaking the molecules into charged fragments and detecting the different charges. MS analysis is highly reliable if the instrument is of sufficient resolution and the technician’s interpretation of the results is competent.</p><p>The chemical components of FOFB were examined by GC-MS thereby 12 components were identified (<xref ref-type="table" rid="table1">Table 1</xref>). The main components of fatty oil with concentrations higher than 1.5% as percentage peak areas were 8,11-octadecadienoic acid (83.75%), palmitic acid (10.22%), octadecadienoic acid (2.97%) and 9-octade- cenoic acid (1.69%), respectively.</p></sec><sec id="s3_2"><title>3.2. Effects of FOFB Diets on the Organs and Body Weight</title><p>Fatty acid compositions of the three experimental diets were determined by GC (<xref ref-type="table" rid="table2">Table 2</xref>). All animals fed with the experimental diets appeared healthy without observable pathological signs or abnormalities during the feeding period. Rats fed with FOFB showed no significant differences in food intaking (g/day/rat), body weight gain and relative organs weights among different diets fed rats. However, epididymal fat pad was significantly decreased (P &lt; 0.05) in both the groups with 5% and 10% FOFB; adipose tissue weight and relative adipose tissue weight were significantly diminished (P &lt; 0.05) in 10% FOFB group (<xref ref-type="table" rid="table3">Table 3</xref>).</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Chemical constituents and contents of oil in FB</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >No.</th><th align="center" valign="middle" >Component</th><th align="center" valign="middle" >Formula</th><th align="center" valign="middle" >Molecule weight</th><th align="center" valign="middle" >Relative content</th></tr></thead><tr><td align="center" valign="middle" >1</td><td align="center" valign="middle" >Tetradecanoic acid</td><td align="center" valign="middle" >C<sub>14</sub>H<sub>28</sub>O<sub>2</sub></td><td align="center" valign="middle" >228</td><td align="center" valign="middle" >0.2</td></tr><tr><td align="center" valign="middle" >2</td><td align="center" valign="middle" >Palmitic acid</td><td align="center" valign="middle" >C<sub>16</sub>H<sub>32</sub>O<sub>2</sub></td><td align="center" valign="middle" >256</td><td align="center" valign="middle" >10.22</td></tr><tr><td align="center" valign="middle" >3</td><td align="center" valign="middle" >8,11-Octadecadienoic acid</td><td align="center" valign="middle" >C<sub>18</sub>H<sub>32</sub>O<sub>2</sub></td><td align="center" valign="middle" >280</td><td align="center" valign="middle" >83.75</td></tr><tr><td align="center" valign="middle" >4</td><td align="center" valign="middle" >9-Octadecenoic acid</td><td align="center" valign="middle" >C<sub>18</sub>H<sub>34</sub>O<sub>2</sub></td><td align="center" valign="middle" >282</td><td align="center" valign="middle" >1.69</td></tr><tr><td align="center" valign="middle" >5</td><td align="center" valign="middle" >Octadecanoic acid</td><td align="center" valign="middle" >C<sub>18</sub>H<sub>36</sub>O<sub>2</sub></td><td align="center" valign="middle" >284</td><td align="center" valign="middle" >2.97</td></tr><tr><td align="center" valign="middle" >6</td><td align="center" valign="middle" >9,12-octadecadienoic acid</td><td align="center" valign="middle" >C<sub>18</sub>H<sub>32</sub>O<sub>2</sub></td><td align="center" valign="middle" >280</td><td align="center" valign="middle" >0.37</td></tr><tr><td align="center" valign="middle" >7</td><td align="center" valign="middle" >11,14-Eicosadienoic acid</td><td align="center" valign="middle" >C<sub>20</sub>H<sub>36</sub>O<sub>2</sub></td><td align="center" valign="middle" >308</td><td align="center" valign="middle" >0.3</td></tr><tr><td align="center" valign="middle" >8</td><td align="center" valign="middle" >11-Eicosenoic acid</td><td align="center" valign="middle" >C<sub>20</sub>H<sub>38</sub>O<sub>2</sub></td><td align="center" valign="middle" >310</td><td align="center" valign="middle" >0.21</td></tr><tr><td align="center" valign="middle" >9</td><td align="center" valign="middle" >Eicosenoic acid</td><td align="center" valign="middle" >C<sub>20</sub>H<sub>40</sub>O<sub>2</sub></td><td align="center" valign="middle" >312</td><td align="center" valign="middle" >0.1</td></tr><tr><td align="center" valign="middle" >10</td><td align="center" valign="middle" >Docosanoic acid</td><td align="center" valign="middle" >C<sub>22</sub>H<sub>44</sub>O<sub>2</sub></td><td align="center" valign="middle" >340</td><td align="center" valign="middle" >0.08</td></tr><tr><td align="center" valign="middle" >11</td><td align="center" valign="middle" >δ-Tocopherol</td><td align="center" valign="middle" >C<sub>27</sub>H<sub>46</sub>O<sub>2</sub></td><td align="center" valign="middle" >402</td><td align="center" valign="middle" >0.08</td></tr><tr><td align="center" valign="middle" >12</td><td align="center" valign="middle" >Fucosterol</td><td align="center" valign="middle" >C<sub>29</sub>H<sub>48</sub>O</td><td align="center" valign="middle" >412</td><td align="center" valign="middle" >0.03</td></tr></tbody></table></table-wrap><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Fatty acid composition of dietary fats (%)</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Fatty acid (carbons (unsaturated carbons))</th><th align="center" valign="middle" >Control</th><th align="center" valign="middle" >5% FOFB</th><th align="center" valign="middle" >10% FOFB</th></tr></thead><tr><td align="center" valign="middle" >14 (0)</td><td align="center" valign="middle" >2.21</td><td align="center" valign="middle" >1.15</td><td align="center" valign="middle" >0.20</td></tr><tr><td align="center" valign="middle" >16 (0)</td><td align="center" valign="middle" >25.24</td><td align="center" valign="middle" >17.81</td><td align="center" valign="middle" >10.22</td></tr><tr><td align="center" valign="middle" >16 (1)</td><td align="center" valign="middle" >4.35</td><td align="center" valign="middle" >2.14</td><td align="center" valign="middle" >trace</td></tr><tr><td align="center" valign="middle" >18 (0)</td><td align="center" valign="middle" >12.99</td><td align="center" valign="middle" >8.04</td><td align="center" valign="middle" >2.97</td></tr><tr><td align="center" valign="middle" >18 (1)</td><td align="center" valign="middle" >41.48</td><td align="center" valign="middle" >21.58</td><td align="center" valign="middle" >1.69</td></tr><tr><td align="center" valign="middle" >18 (2)</td><td align="center" valign="middle" >13.26</td><td align="center" valign="middle" >48.53</td><td align="center" valign="middle" >84.05</td></tr><tr><td align="center" valign="middle" >SFA</td><td align="center" valign="middle" >40.44</td><td align="center" valign="middle" >27.00</td><td align="center" valign="middle" >13.39</td></tr><tr><td align="center" valign="middle" >PUFA</td><td align="center" valign="middle" >13.26</td><td align="center" valign="middle" >48.53</td><td align="center" valign="middle" >84.05</td></tr><tr><td align="center" valign="middle" >MUFA</td><td align="center" valign="middle" >45.83</td><td align="center" valign="middle" >23.72</td><td align="center" valign="middle" >1.69</td></tr><tr><td align="center" valign="middle" >P/S</td><td align="center" valign="middle" >0.33</td><td align="center" valign="middle" >1.80</td><td align="center" valign="middle" >6.28</td></tr><tr><td align="center" valign="middle" >(P + M)/S</td><td align="center" valign="middle" >1.46</td><td align="center" valign="middle" >2.68</td><td align="center" valign="middle" >6.40</td></tr><tr><td align="center" valign="middle" >P/M</td><td align="center" valign="middle" >0.29</td><td align="center" valign="middle" >2.05</td><td align="center" valign="middle" >49.73</td></tr><tr><td align="center" valign="middle" >M/S</td><td align="center" valign="middle" >1.13</td><td align="center" valign="middle" >0.88</td><td align="center" valign="middle" >0.13</td></tr></tbody></table></table-wrap><p>SFA: saturated fatty acid. PUFA: polyunsaturated fatty acid. MUFA: monounsaturated fatty acid.</p><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Changes in body weight, food intake, liver and adipose tissue weight in rats fed different experimental diets for 4 weeks</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Group</th><th align="center" valign="middle" >Control</th><th align="center" valign="middle" >5% FOFB</th><th align="center" valign="middle" >10% FOFB</th></tr></thead><tr><td align="center" valign="middle" >Initial body weight (g)</td><td align="center" valign="middle" >176.13 &#177; 4.59</td><td align="center" valign="middle" >176.15 &#177; 4.21</td><td align="center" valign="middle" >176.14 &#177; 4.29</td></tr><tr><td align="center" valign="middle" >Final body weight (g)</td><td align="center" valign="middle" >222.15 &#177; 19.48</td><td align="center" valign="middle" >219.40 &#177; 9.34</td><td align="center" valign="middle" >221.00 &#177; 6.88</td></tr><tr><td align="center" valign="middle" >Food intake (g/day)</td><td align="center" valign="middle" >16.96 &#177; 2.13</td><td align="center" valign="middle" >17.26 &#177; 1.98</td><td align="center" valign="middle" >17.32 &#177; 2.15</td></tr><tr><td align="center" valign="middle" >Heart weight (g)</td><td align="center" valign="middle" >4.721&#177; 0.66</td><td align="center" valign="middle" >4.78 &#177; 0.69</td><td align="center" valign="middle" >4.76 &#177; 0.78</td></tr><tr><td align="center" valign="middle" >Relative heart weight</td><td align="center" valign="middle" >2.12 &#177; 0.71</td><td align="center" valign="middle" >2.18 &#177; 0.91</td><td align="center" valign="middle" >2.15 &#177; 0.79</td></tr><tr><td align="center" valign="middle" >Liver weight (g)</td><td align="center" valign="middle" >7.06 &#177; 0.52</td><td align="center" valign="middle" >7.08 &#177; 1.23</td><td align="center" valign="middle" >7.04 &#177; 0.91</td></tr><tr><td align="center" valign="middle" >Relative liver weight</td><td align="center" valign="middle" >3.73 &#177; 0.13</td><td align="center" valign="middle" >3.70 &#177; 0.26</td><td align="center" valign="middle" >3.68 &#177; 0.49</td></tr><tr><td align="center" valign="middle" >Epididymal fat pad</td><td align="center" valign="middle" >3.38 &#177; 0.20</td><td align="center" valign="middle" >2.98 &#177; 0.96<sup>*</sup></td><td align="center" valign="middle" >2.97 &#177; 0.34<sup>*</sup></td></tr><tr><td align="center" valign="middle" >Abdominal adipose tissue</td><td align="center" valign="middle" >0.72 &#177; 0.28</td><td align="center" valign="middle" >0.63 &#177; 0.14</td><td align="center" valign="middle" >0.59 &#177; 0.15<sup>*</sup></td></tr><tr><td align="center" valign="middle" >Adipose tissue weight (g)</td><td align="center" valign="middle" >4.10 &#177; 0.41</td><td align="center" valign="middle" >3.61 &#177; 0.42</td><td align="center" valign="middle" >3.56 &#177; 0.51<sup>*</sup></td></tr><tr><td align="center" valign="middle" >Relative adipose weight</td><td align="center" valign="middle" >2.17 &#177; 0.37</td><td align="center" valign="middle" >1.92 &#177; 0.24</td><td align="center" valign="middle" >1.89 &#177; 0 .39<sup>*</sup></td></tr></tbody></table></table-wrap><p>Each value is expressed as mean &#177; S.D. for ten rats per dietary group. Values in the same row with asterisk are significantly different. <sup>*</sup> vs. control group P &lt; 0.05.</p><p>This result is in line with previous reports. Diet-induced obesity was related with renal lipid accumulation in mice [<xref ref-type="bibr" rid="scirp.64403-ref14">14</xref>] . Consumption of PUFA diet could increase lipoprotein lipase activity and inhibited body fat accumulation in rats [<xref ref-type="bibr" rid="scirp.64403-ref15">15</xref>] . According to another report, there is no correlation between the type of diet fat and the volume of adipose tissue, whereas the amount of dietary fat and the age of an organism are the factors affecting the volume of adipose tissue [<xref ref-type="bibr" rid="scirp.64403-ref16">16</xref>] . In our study, no difference was found in the amount of the food consumption among groups, but the FOFB groups presented lower adipose tissue levels than the control group upon the completion experiment. PUFA decreases the oxidative stress in plasma and regulates the liver and adipose tissue gene expression such as UCP1 mRNA and SCD1 mRNA, which can delay free fatty acids from entering adipose tissue to form triancyglycerol through esterification, and in turn slow down white body fat accumulation [<xref ref-type="bibr" rid="scirp.64403-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.64403-ref17">17</xref>] [<xref ref-type="bibr" rid="scirp.64403-ref18">18</xref>] . Furthermore, FOFB with major component 8,11-Octadecadienic acid is a powerful natural antioxidant and is able to suppress LPS induced NO production in RAW264.7 macrophages [<xref ref-type="bibr" rid="scirp.64403-ref12">12</xref>] . Excessive free radical and NO production are reported to be associated with various diseases such as obesity [<xref ref-type="bibr" rid="scirp.64403-ref19">19</xref>] .</p></sec><sec id="s3_3"><title>3.3. Effects of Different Doses of FOFB Diets on Plasma Lipids</title><p>To evaluate the effects of FOFB on the regulation of plasma lipids in rats, the total cholesterol, triacylglycerol, HDL-cholesterol and LDL-cholesterol were measured. Our data showed (<xref ref-type="table" rid="table4">Table 4</xref>) that the plasma LDL-cho- lesterol levels were significantly (P &lt; 0.05) decreased in both 5% and 10% FOFB groups respectively. The plasam levels of the total cholesterol, triacylglycerol and LDL-cholesterol were significantly (P &lt; 0.05) decreased in the both groups fed with FOFB, respectively. It has been noticed that the effect of FOFB on reduction level of the LDL-cholesterol was dose-dependent, but on the total cholesterol level was not. This could be explained by the fact that either 5% or 10% FOFB diet had no effect on the HDL-cholesterol (<xref ref-type="table" rid="table4">Table 4</xref>). The effect of FOFB on the plasma triacylglycerol level was not dose-dependent either. This phenomenon could be caused by the effect of MUFA which was contained in the diets. It has been proposed that a large amount of dietary MUFA may raise some fractions of plasma lipids [<xref ref-type="bibr" rid="scirp.64403-ref20">20</xref>] .</p><p>Both of the FOFB groups presented lower level of liver cholesterol (<xref ref-type="table" rid="table5">Table 5</xref>) as well as the plasma LDL- cholesterol. A related study has pointed out that phytosterols can reduce plasma LDL-C [<xref ref-type="bibr" rid="scirp.64403-ref21">21</xref>] . FOFB contains phytosterol such as fucosterol. Higher fucosterol concentration in the liver will result in an increase in the anti- oxidant enzymes such as hepatic cytosolic superoxide dismutase (SOD), catalase and glutathione peroxidase (GSH-px) activities [<xref ref-type="bibr" rid="scirp.64403-ref22">22</xref>] , and inhibit the absorption of chelosterol. The small amount of fucosterol contains in FOFB, which sometimes might be one of the causes of an apparent decrease of hepatic cholesterol in rats.</p><p>In conclusion, FOFB contained a large amount of PUFA about 32% to 35% [<xref ref-type="bibr" rid="scirp.64403-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.64403-ref11">11</xref>] , which had the effect on reducing plasma lipids and adipose. Our future work will investigate the mechanisms underlying the activities of</p><table-wrap id="table4" ><label><xref ref-type="table" rid="table4">Table 4</xref></label><caption><title> Changes in plasma lipids and lipoprotein cholesterol in rats fed with different types of diets for 4 weeks</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Group</th><th align="center" valign="middle" >Control</th><th align="center" valign="middle" >5% FOFB</th><th align="center" valign="middle" >10% FOFB</th></tr></thead><tr><td align="center" valign="middle" >Total cholesterol (mg/dl)</td><td align="center" valign="middle" >326.16 &#177; 58.78</td><td align="center" valign="middle" >287.59 &#177; 77.60<sup>*</sup></td><td align="center" valign="middle" >298.42 &#177; 56.05<sup>*</sup></td></tr><tr><td align="center" valign="middle" >Triacylglycerol (mg/dl)</td><td align="center" valign="middle" >49.37 &#177; 8.53</td><td align="center" valign="middle" >42.51 &#177; 9.18<sup>*</sup></td><td align="center" valign="middle" >43.24 &#177; 10.70<sup>*</sup></td></tr><tr><td align="center" valign="middle" >HDL-cholesterol (mg/dl)</td><td align="center" valign="middle" >16.38 &#177; 2.50</td><td align="center" valign="middle" >16.00 &#177; 2.67</td><td align="center" valign="middle" >16.51 &#177; 2.23</td></tr><tr><td align="center" valign="middle" >LDL-cholesterol (mg/dl)</td><td align="center" valign="middle" >8.83 &#177; 1.318</td><td align="center" valign="middle" >7.76 &#177; 1.99<sup>*</sup></td><td align="center" valign="middle" >7.59 &#177; 2.32<sup>*</sup></td></tr></tbody></table></table-wrap><p>Each value is expressed as mean &#177; S.D. for ten rats per dietary group. Values in the same row with asterisk are significantly different. <sup>*</sup> vs control group P &lt; 0.05.</p><table-wrap id="table5" ><label><xref ref-type="table" rid="table5">Table 5</xref></label><caption><title> Changes in liver lipid in rats fed with different types of diets for 4 weeks</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Group</th><th align="center" valign="middle" >Control</th><th align="center" valign="middle" >5% FOFB</th><th align="center" valign="middle" >10% FOFB</th></tr></thead><tr><td align="center" valign="middle" >Cholesterol</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >(mg/liver)</td><td align="center" valign="middle" >756.23 &#177; 67.20</td><td align="center" valign="middle" >669.19 &#177; 88.11<sup>*</sup></td><td align="center" valign="middle" >613.88 &#177; 51.61<sup>*</sup></td></tr><tr><td align="center" valign="middle" >(mg/g liver)</td><td align="center" valign="middle" >107.24 &#177; 7.53</td><td align="center" valign="middle" >94.50 &#177; 8.44<sup>*</sup></td><td align="center" valign="middle" >87.28 &#177; 10.70<sup>*</sup></td></tr></tbody></table></table-wrap><p>Each value is expressed as mean &#177; S.D. for ten rats per dietary group. Values in the same row with asterisk are significantly different. <sup>*</sup> vs control group P &lt; 0.05.</p><p>each component of FOFB to provide data for development of an antihyperlipidemic agent.</p></sec></sec><sec id="s4"><title>Acknowledgements</title><p>This work was supported by the Quanzhou Science &amp; Technology Fund (2007Z12).</p></sec><sec id="s5"><title>Cite this paper</title><p>Su-Qiu Pang,Guo-Quan Wang,Xiao-Qin Jin,Ai-Jing Sun,Jun-Sheng Lin,Yong Diao, (2016) Chemical Composition of the Fatty Oil from Fructus Broussonetiae and Its Effects on Rat Plasma Lipids and Adipose Tissue. American Journal of Plant Sciences,07,446-452. doi: 10.4236/ajps.2016.73038</p></sec><sec id="s6"><title>NOTES</title></sec></body><back><ref-list><title>References</title><ref id="scirp.64403-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Pharmacopoeia Commission of People’s Republic of China (2010) Pharmacopoeia of People’s Republic of China. Chinese Medical Science &amp; Technology Press, Beijing, 315.</mixed-citation></ref><ref id="scirp.64403-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Matsuda, H., Cai, H., Kubo, M., Tosa, H. and Iinuma, M. (1995) Study on Anti-Cataract Drugs from Natural Sources. II. Effects of Buddlejae Flos on in Vitro Aldose Reductase Activity. Biological &amp; Pharmaceutical Bulletin, 18, 463-466. http://dx.doi.org/10.1248/bpb.18.463</mixed-citation></ref><ref id="scirp.64403-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Li, Z.M., Chen, J.J. and Yan, M.H. (2010) Studies on Chemical Constituents of Cortex of Broussonetia papyrifera. Journal of Anhui Agriculture Science, 38, 7288-7290.</mixed-citation></ref><ref id="scirp.64403-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Pang, S.Q., Wang, G.Q., Huang, B.K., et al. (2007) Cytotoxic Activities of Total Alkaloids Isolated from Fructus Broussonetia in Vitro. Journal of Chinese Medicinal Materials, 30, 826-828.</mixed-citation></ref><ref id="scirp.64403-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Guo, M.X., Wang, M.L., Deng, H., et al. (2013) A Novel Anticancer Agent Broussoflavonol B Downregulates Estrogen Receptor (ER)-α36 Expression and Inhibits Growth of ER-Negative Breast Cancer MDA-MB-231 Cells. European Journal of Pharmacology, 714, 56-64. http://dx.doi.org/10.1016/j.ejphar.2013.05.047</mixed-citation></ref><ref id="scirp.64403-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Pang, S.Q., Wang, G.Q., Qin, L.P., Huang, B.K. and Zhang, Q.Y. (2006) Antioxidation Activities of Fructus Broussonetia Haematochrome in Vitro. Journal of Chinese Medicinal Materials, 29, 262-265.</mixed-citation></ref><ref id="scirp.64403-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Matsuo, T., Takeuchi, H., Suzuki, H., Suzuki, H. and Suzuki, M. (2002) Body Fat Accumulation Is Greater in Rats Fed a Beef Tallow Diet than in Rats Fed a Safflower or Soybean Oil Diet. Asia Pacific Journal of Clinical Nutrition, 11, 302-308. http://dx.doi.org/10.1046/j.1440-6047.2002.00299.x</mixed-citation></ref><ref id="scirp.64403-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Li, Y.H., Hu, L. and Wu, Z.Z. (2011) Fructus Broussonetae Extract Improves Cognitive Function and Endoplasmic Reticulum Stress in Alzheimer’s Disease Models. Neural Regeneration Research, 6, 2325-2331.</mixed-citation></ref><ref id="scirp.64403-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Huang, B.K., Qin, L.P., Zheng, H.C., et al. (2003) Analysis of Amino Acid and Fatty Acid of Fructus Broussonetiae. Acadamic Journal of Second Military Medical University, 24, 213-213,217,227.</mixed-citation></ref><ref id="scirp.64403-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Fukuda, H., Iritani, N., Sugimoto, T. and Ikeda, H. (1999) Transcriptional Regulation of Fatty Acid Synthase Gene by Insulin/Glucose, Polyunsaturated Fatty Acid and Leptin in Hepatocytes and Adipocytes in Normal and Genetically Obese Rats. European Journal of Biochemistry, 260, 505-511. http://dx.doi.org/10.1046/j.1432-1327.1999.00183.x</mixed-citation></ref><ref id="scirp.64403-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Yuan, X. and Yuan, P. (2005) Studies on the Effects of Oil and Flavanoids from Fructus Broussonetiae’s Antioxidation and Elimination of Free Radicals. Natural of Product Research Developing, 17, 23-26.</mixed-citation></ref><ref id="scirp.64403-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Zhao, H., Huang, L., Qin, L., et al. (2011) Antioxidative and Anti-Inflammatory Properties of Chushizi Oil from Fructus Broussonetiae. Journal of Medicinal Plants Research, 5, 6407-6412.</mixed-citation></ref><ref id="scirp.64403-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Folch, J., Less, M. and Sloane, G.H. (1957) A Simple Method for the Isolation and Purification of Total Lipids from Animal Tissue. Journal of Biological Chemistry, 226, 497-509.</mixed-citation></ref><ref id="scirp.64403-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Jiang, T., Wang, Z.W., Proctor, G., et al. (2005) Diet-Induced Obesity in C57BL/6J Mice Causes Increased Renal Lipid Accumulation and Glomerulosclerosis via a Sterol Regulatory Element-Binding Protein-1c-Dependent Pathway. Journal of Biological Chemistry, 280, 32317-32325. http://dx.doi.org/10.1074/jbc.M500801200</mixed-citation></ref><ref id="scirp.64403-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Shimomura, Y., Tamura, T. and Suzuki, M. (1990) Less Body Fat Accumulation in Rats Fed a Safflower Oil Diet than in Rats Fed a Beef Tallow Diet. Journal of Nutrition, 120, 1291-1296.</mixed-citation></ref><ref id="scirp.64403-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Edwards, M.S., Smith, B.A., Kainer, R.A., et al. (1993) Effect of Dietary Fat and Aging on Adipose Tissue Cellularity in Mice Differing in Genetic Predisposition to Obesity. Growth Development of Aging, 57, 45-51.</mixed-citation></ref><ref id="scirp.64403-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Jones, B.H., Maher, M.A., Banz, W.J., et al. (1996) Adipose Tissue Stearoyl-CoA Desaturase mRNA Is Increased by Obesity and Decreased by Polyunsaturated Fatty Acids. American Journal of Physiology, 271, E44-E49.</mixed-citation></ref><ref id="scirp.64403-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Sessler, A.M. and Ntambi, J.M. (1998) Polyunsaturated Fatty Acid Regulation of Gene Expression. The Journal of Nutrition, 128, 923-926.</mixed-citation></ref><ref id="scirp.64403-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Luo, R. and Qu, S.Y. (2004) Obesity and Free Radicals. Section of Endocrinology Foreign Medical Sciences, 24, 9-10.</mixed-citation></ref><ref id="scirp.64403-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Chang, N.W. and Huang, P.C. (1990) Effects of Dietary Monounsaturated Fatty Acids on Plasma Lipids in Humans. Journal of Lipid Research, 3, 2141-2147.</mixed-citation></ref><ref id="scirp.64403-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Nigon, F., Serfaty-Lacrosnière, C., Beucler, I., et al. (2001) Plant Sterol-Enriched Margarine Lowers Plasma LDL in Hyperlipidemic Subjects with Low Cholesterol Intake: Effect of Fibrate Treatment. Clinical Chemistry and Laborotary Medicine, 39, 634-640. http://dx.doi.org/10.1515/cclm.2001.103</mixed-citation></ref><ref id="scirp.64403-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Lee, S., Lee, Y.S., Jung, S.H., Kang, S.S. and Shin, K.H. (2003) Anti-Oxidant Activities of Fucosterol from the Marine Algae Pelvetia siliquosa. Archives of Pharmacal Research, 26, 719-722. http://dx.doi.org/10.1007/BF02976680</mixed-citation></ref></ref-list></back></article>